RUNX1 and pulmonary arterial hypertension: Although the role of RUNX1 in the pathophysiology of PAH is not yet known, one hypothesis is that disruptions in endothelial progenitor cell (EPC) fate from definitive endothelium to hematopoietic or myeloid fate may explain inadequate vascular repair and perivascular infiltrates in patients with PAH.